Evidence map›Paper›PMID 26647645›Full record

ArticleNanotoxicology2016

A combined proteomics and metabolomics approach to assess the effects of gold nanoparticles in vitro.

Sabrina Gioria, Joana Lobo Vicente, Paola Barboro, Rita La Spina, Giorgio Tomasi, Patricia Urbán, Agnieszka Kinsner-Ovaskainen, Rossi François, Hubert Chassaigne

Abstract read
In one paragraph

Article in Nanotoxicology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Deciphering the mechanism of action of antitubercular compounds with metabolomics.Computational and structural biotechnology journal · 2021
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sabrina Gioriaa European Commission, Joint Research Centre, Institute for Health and Consumer Protection , Ispra , Italy and.
Joana Lobo Vicentea European Commission, Joint Research Centre, Institute for Health and Consumer Protection , Ispra , Italy and.
Paola Barborob IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro , Genova , Italy.
Rita La Spinaa European Commission, Joint Research Centre, Institute for Health and Consumer Protection , Ispra , Italy and.
Giorgio Tomasia European Commission, Joint Research Centre, Institute for Health and Consumer Protection , Ispra , Italy and.
Patricia Urbána European Commission, Joint Research Centre, Institute for Health and Consumer Protection , Ispra , Italy and.
Agnieszka Kinsner-Ovaskainena European Commission, Joint Research Centre, Institute for Health and Consumer Protection , Ispra , Italy and.
Rossi Françoisa European Commission, Joint Research Centre, Institute for Health and Consumer Protection , Ispra , Italy and.
Hubert Chassaignea European Commission, Joint Research Centre, Institute for Health and Consumer Protection , Ispra , Italy and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Omics technologies, such as proteomics or metabolomics, have to date been applied in the field of nanomaterial safety assessment to a limited extent. To address this dearth, we developed an integrated approach combining the two techniques to study the effects of two sizes, 5 and 30 nm, of gold nanoparticles (AuNPs) in Caco-2 cells. We observed differences in cells exposed for 72 h to each size of AuNPs: 61 responsive (up/down-regulated) proteins were identified and 35 metabolites in the cell extract were tentatively annotated. Several altered biological pathways were highlighted by integrating the obtained multi-omics data with bioinformatic tools. This provided a unique set of molecular information on the effects of nanomaterials at cellular level. This information was supported by complementary data obtained by immunochemistry, microscopic analysis, and multiplexed assays. A part from increasing our knowledge on how the cellular processes and pathways are affected by nanomaterials (NMs), these findings could be used to identify specific biomarkers of toxicity or to support the safe-by-design concept in the development of new nanomedicines.

Indexed as

BiomarkersCaco-2 CellsCell Culture TechniquesCytoplasmGoldHumansMetabolomicsMetal NanoparticlesProteomicsBiomarkersGoldLiquid chromatography high-resolution tandem mass spectrometry (LC-HRMS/MS)omics data treatmentsystems biology analysistwo-dimensional gel electrophoresis (2DE)

Identifiers

PMID26647645
PMCPMC4898143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.